Sign in
8-K

Current Report

Cartesian Therapeutics, Inc. Filed Acc 0001453687-17-000024

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading selectabiosciences8k_lmb-1.htm…